What question did this study set out to answer?

To assess the appropriateness of the current severity-based treatment model for iMCD-IPL patients and analyze their treatment outcomes.

December 8, 2025Blood

Is 'severe’ imcd-IPL really severe?

View Full Paper

Ask AI

Bookmark

Authors

SLSiyuan LiChinese Academy of Medical Sciences & Peking Union Medical College

Discussion

Member takes

Implication

Retrospective analysis reveals treatment responses and safety profiles of severe iMCD-IPL patients with adverse events, suggesting a need for reevaluation of treatment protocols.

Key Points

To assess the appropriateness of the current severity-based treatment model for iMCD-IPL patients and analyze their treatment outcomes.
Retrospective study of patients with iMCD-IPL and iMCD-NOS at Peking Union Medical College Hospital.
Patients were classified into groups based on CDCN severity criteria.
Kaplan-Meier curves evaluated overall survival, comparing outcomes among patient subgroups.
No significant difference in overall survival between severe iMCD-IPL and non-severe iMCD-NOS.
Severe iMCD-IPL patients did not reflect expected outcomes based on severity-based treatment.
Adverse events were noted in the 'severe-type' therapy group, indicating safety concerns.

Cite This Study

Siyuan Li (2025) studied this question.

synapsesocial.com/papers/69362f3d4fa91c937236d482 https://doi.org/10.1182/blood-2025-1816

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis reveals treatment responses and safety profiles of severe iMCD-IPL patients with adverse events, suggesting a need for reevaluation of treatment protocols.

Is 'severe’ imcd-IPL really severe?

Discussion

Member takes

Implication

Key Points

Cite This Study

Is 'severe’ imcd-IPL really severe?

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider